Expression of CD371 is almost unique to the DUX4-r B-ALL [74, 75] and CAR T cell immunotherapy targeting CD371 has been shown to have a potent anti-leukaemic effect on DUX4-r cell populations [72]. Here, CLEC12A is linked to acute lymphoblastic leukemia.